Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: South Korea Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20092
20106
20111
20121
20141
20151
20164
20171
20185
20193
20202
20212
20225
20234
20242
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15
Completed13
Active, not recruiting11
Unknown status6
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
AstraZeneca4
AbbVie3
Merck Sharp & Dohme LLC3
Seoul National University Hospital3
Amgen2
Corcept Therapeutics2
Regeneron Pharmaceuticals2
AGO Study Group1
Advenchen Laboratories, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms49
Ovarian Neoplasms38
Carcinoma, Ovarian Epithelial14
Peritoneal Neoplasms7
Endometrial Neoplasms5
Neoplasms4
Brenner Tumor3
Neoplasm Metastasis3
Uterine Cervical Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.